Group One Trading’s Biocept, Inc. BIOC Stock Holding History

Group One Trading’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-333	Closed	-$9K	–	8525
2022 Q2	$9K	Hold	333	–	–	﹤0.01%	6847
2022 Q1	$23K	Buy	+333	New	+$26.2K	﹤0.01%	6680
2021 Q4	–	Sell	-10	Closed	-$1K	–	9057
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	8067
2021 Q2	$1K	Buy	+10	New	+$1.35K	﹤0.01%	8051

Group One Trading's BIOC Position: Q4 2023 in Review

Group One Trading sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 270 shares — an estimated $338 sold.

Group One Trading first reported a position in BIOC in Q3 2018 and held it in 18 quarters. The position peaked at $63K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

Group One Trading reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 270 Biocept, Inc. shares in Q4 2023, an estimated $338.
Group One Trading first reported a position in Biocept, Inc. in Q3 2018 and held it in 18 quarters.
Group One Trading's Biocept, Inc. position peaked at $63K in Q4 2021.
0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.